Last updated: December 18, 2023
Sponsor: Wujin People's Hospital
Overall Status: Completed
Phase
N/A
Condition
Adverse Effects, Drugs
Treatment
cardiac catheterization via distal radial artery
Clinical Study ID
NCT05317533
CLH20220312
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years;
- Palpable distal radial artery
Exclusion
Exclusion Criteria:
- Age ≥ 90years;
- Height≥ 185cm;
- Cardiogenic shock;
- Refuse to sign the written informed consent.
Study Design
Total Participants: 805
Treatment Group(s): 1
Primary Treatment: cardiac catheterization via distal radial artery
Phase:
Study Start date:
March 01, 2022
Estimated Completion Date:
December 18, 2023
Study Description
Connect with a study center
Changzhou Wujin People's Hospital
Changzhou, Jiangsu 213017
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.